NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/28/2024
Back to search
Official data from USPTO
ANGITIA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
05/28/2024
Trademark type
Word
Nice classes
5
Filing date
03/15/2022
Registration date
05/28/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/28/2024
Last transaction
05/28/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
Drawing code
4
Owner type
16
Owner location
Guangzhou, Guangdong, CN
Examiner
REINHART, MEGHAN M
Law office
L80
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Angitia Biopharmaceuticals Guangzhou Limited
Representatives
Kevin O'Keefe KEEFER-A
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Antiallergic medicines; Biological tissue grafts; Bone cement for medical purposes; Bone growth media consisting of biological materials for medical purposes; Cement for bones for medical use; Dietetic foods adapted for medical use; Dietetic preparations adapted for medical purposes; Implants comprising living tissue; Medical dressings; Medicinal preparations for preventing osteoporosis; Medicines for alleviating constipation; Medicines for dental purposes; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for the central nervous system; Pharmaceutical preparations for the treatment of bone fractures; Pharmaceutical preparations for the treatment of hormonal disorders; Pharmaceutical preparations for the treatment of musculo-skeletal disorders; Pharmaceutical preparations for wounds; Pharmaceutical preparations for skin wounds; Teeth filling material; Thyroid and para-thyroid hormone preparations; Tumor suppressing agents; Vitamin D preparations
Publications
History of USPTO decisions and trademark events.
28 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/28/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/12/2024
PUBO
PUBLISHED FOR OPPOSITION
03/12/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/21/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/21/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/06/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
02/06/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/06/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
02/06/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/06/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/19/2023
GNRT
NON-FINAL ACTION E-MAILED
10/19/2023
CNRT
NON-FINAL ACTION WRITTEN
10/19/2023
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
10/19/2023
OTHE
CASE RETURNED TO EXAMINATION
10/12/2023
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
10/12/2023
APET
ASSIGNED TO PETITION STAFF
10/11/2023
IUCN
NOTICE OF ALLOWANCE CANCELLED
09/28/2023
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
09/21/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/28/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/31/2023
PUBO
PUBLISHED FOR OPPOSITION
01/31/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/11/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/27/2022
DOCK
ASSIGNED TO EXAMINER
12/27/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/21/2022
NWAP
NEW APPLICATION ENTERED
03/18/2022
Continuous trademark protection
Get notified about every new filing that threatens ANGITIA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.